Giant Biogene Holding Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2,062	1,452	1,002	828.13
Depreciation & Amortization	48.98	33.69	27.24	23.94
Other Amortization	0.51	0.48	0.39	0.27
Loss (Gain) From Sale of Assets	-0.56	2.88	2.91	0.18
Loss (Gain) From Sale of Investments	-43.27	-29.33	8.28	-14.47
Loss (Gain) on Equity Investments	3.6	-	-	-
Stock-Based Compensation	89.72	20.52	17.66	16.49
Provision & Write-off of Bad Debts	0.94	-0.03	-0.15	0.05
Other Operating Activities	-94.83	39.65	4.94	-104.34
Change in Accounts Receivable	-40.2	-32.58	-3.64	-11.16
Change in Inventory	-113.51	-17.77	-94.36	-24.61
Change in Accounts Payable	153.6	78.46	31.04	-8.33
Change in Unearned Revenue	-19.22	24.7	-3.23	13.54
Change in Other Net Operating Assets	-6.92	75.01	-61.49	-27.28
Operating Cash Flow	2,041	1,647	931.64	692.4
Operating Cash Flow Growth	23.90%	76.83%	34.55%	-16.99%
Capital Expenditures	-246.77	-226.3	-152.66	-75
Divestitures	-3.69	33.13	-	-
Sale (Purchase) of Intangibles	-0.01	-2.13	-0.59	-0.13
Sale (Purchase) of Real Estate	-	-	-	-19.53
Investment in Securities	-967	-379.47	-718.65	1,447
Other Investing Activities	111.35	47.49	13.16	210.72
Investing Cash Flow	-1,106	-527.28	-858.74	1,563
Long-Term Debt Repaid	-4.18	-1.05	-0.19	-
Net Debt Issued (Repaid)	-4.18	-1.05	-0.19	-
Issuance of Common Stock	1,504	56.4	583.51	0.06
Repurchase of Common Stock	-	-	-6,236	-
Common Dividends Paid	-908.44	-	-	-
Dividends Paid	-908.44	-	-367.46	-2,550
Other Financing Activities	-7.97	-3.54	-11.67	-68.62
Financing Cash Flow	582.95	51.81	-5,790	4,476
Foreign Exchange Rate Adjustments	8.18	1.09	-55.18	3.98
Net Cash Flow	1,526	1,173	-5,772	6,735
Free Cash Flow	1,794	1,421	778.97	617.4
Free Cash Flow Growth	26.27%	82.44%	26.17%	-18.62%
Free Cash Flow Margin	32.40%	40.33%	32.95%	39.77%
Free Cash Flow Per Share	1.79	1.45	0.76	0.62
Cash Income Tax Paid	385	205.76	172.7	218.26
Levered Free Cash Flow	1,442	1,057	-6,104	5,352
Unlevered Free Cash Flow	1,442	1,057	-6,104	5,352
Change in Working Capital	-26.24	127.81	-131.67	-57.85

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.